Table 2 PEDro scores of included trials (n = 5)
Study | Eligibility and sourcea | Random allocation | Concealed allocation | Groups similar at baseline | Participant blinding | Therapist blinding | Assessor blinding | < 15% lost to follow-up | Intention-to- treat analysis | Between-group difference reported point | Point estimate and variability reported | Total (0–10) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bauer et al. [17] | N | Y | N | Y | N | N | Y | Y | Y | Y | Y | 7 |
Ambrosini et al. [18] | Y | Y | Y | Y | N | N | N | Y | N | Y | Y | 6 |
Peri et al. [19] | N | Y | Y | Y | N | N | Y | Y | N | Y | Y | 7 |
Lee et al. [24] | Y | Y | N | Y | N | N | N | N | N | Y | Y | 4 |
Zhang et al. [25] | Y | Y | N | Y | N | N | N | Y | N | Y | Y | 5 |